| Page No 1 2 3 |
| Phrase | Consultant | Town | Special Interests |
| Clinical apheresis | *Consultant(s)* | *Towns* | Clinical apheresis, haemostasis and thrombosis |
| clinical e-health | *Consultant(s)* | *Towns* | HIV medicine, epidemiology of sexually transmitted infections, clinical e-health, new diagnostic platforms for STIs |
| clinical ethics | *Consultant(s)* | *Towns* | Hyperbaric medicine, clinical ethics |
| Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics, inherited vascular diseases |
| Clinical Genetics | *Consultant(s)* | *Towns* | Pallister Killian syndrome |
| Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics |
| Clinical Genetics | *Consultant(s)* | *Towns* | Paediatric genetics, developmental disorders, cardiac genetics |
| Clinical Genetics | *Consultant(s)* | *Towns* | Learning disability, dermatology |
| Clinical Genetics | *Consultant(s)* | *Towns* | Hypomelanosis of Ito, familial arrhythmia |
| Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics |
| Clinical Genetics | *Consultant(s)* | *Towns* | Neuromuscular genetics |
| Clinical Genetics | *Consultant(s)* | *Towns* | Duchenne muscular dystrophy family screening |
| Clinical Genetics | *Consultant(s)* | *Towns* | Familial arrhythmia, cleft lip and palate with associated digital and cardiac anomalies |
| Clinical Genetics | *Consultant(s)* | *Towns* | Idiopathic talipes, autism, Huntington's disease, cancer genetics, molecular pathology |
| Clinical Genetics | *Consultant(s)* | *Towns* | Cortical malformations - brain, neuronal migration disorders |
| Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics |
| Clinical Genetics | *Consultant(s)* | *Towns* | Renal genetics, cardiovascular genetics |
| Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics, research |
| Clinical Genetics | *Consultant(s)* | *Towns* | Cancer genetics |
| Clinical governance | *Consultant(s)* | *Towns* | Clinical governance |
| clinical governance | *Consultant(s)* | *Towns* | Intensive care, clinical governance |
| clinical governance/risk management | *Consultant(s)* | *Towns* | Medical management, clinical governance/risk management, maternal and fetal medicine, ultrasound |
| clinical improvement - flow coach | *Consultant(s)* | *Towns* | Respiratory medicine, cardiology, obstructive sleep apnoea - noninvasive ventilation, asthma, COPD, interstitial lung disease, lung cancer, palliative care, clinical lead, clinical improvement - flow coach |
| clinical informatics | *Consultant(s)* | *Towns* | Lipid disorders, assessment of renal function, clinical informatics, point of care testing |
| clinical lead | *Consultant(s)* | *Towns* | Respiratory medicine, cardiology, obstructive sleep apnoea - noninvasive ventilation, asthma, COPD, interstitial lung disease, lung cancer, palliative care, clinical lead, clinical improvement - flow coach |
| Clinical Lead | *Consultant(s)* | *Towns* | Clinical Lead |
| clinical MR spectroscopy | *Consultant(s)* | *Towns* | Imaging in dementia and brain neoplasia, clinical MR spectroscopy |
| Clinical Neurophysiology | *Consultant(s)* | *Towns* | Epilepsy, peripheral nerve disorders |
| Clinical Neurophysiology | *Consultant(s)* | *Towns* | Nerve conduction studies, epilepsy, peripheral nerve and muscle disease |
| clinical nutrition | *Consultant(s)* | *Towns* | Colorectal surgery, clinical nutrition |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast malignancies, urological malignancies |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, head and neck cancer, maxillofacial cancers, radiotherapy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, urological cancer, renal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, chemotherapy, immunotherapy, metastatic cancer, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, urological oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer, neuro-oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, lung cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, paediatric oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, genito-urinary cancers, skin cancer |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, head and neck oncology, upper gastrointestinal malignancy |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, tumours of the thorax and lower gastrointestinal tract |
| Clinical oncology | *Consultant(s)* | *Towns* | Clinical oncology, breast cancer, lung cancer and mesothelioma |
| Page No 1 2 3 |
